牛牛AI助理已提取核心訊息
On February 26, 2024, Aclarion, Inc., a company listed on the United States Securities and Exchange Commission, experienced a significant event involving the filing of a Schedule 13G amendment. The filing was made by Mitchell P. Kopin, Daniel B. Asher, and Intracoastal Capital LLC, collectively referred to as the Reporting Persons. The Schedule 13G indicates that these Reporting Persons have shared voting and dispositive power over 375,554 shares of Aclarion's common stock, which represents approximately 4.99% of the company's class of securities. This filing was necessitated by a transaction that occurred on the same date, as detailed in a Securities Purchase Agreement (SPA) with Aclarion, which was disclosed in a Form 8-K filed with the SEC on February 27, 2024. The Reporting Persons may have been...Show More
On February 26, 2024, Aclarion, Inc., a company listed on the United States Securities and Exchange Commission, experienced a significant event involving the filing of a Schedule 13G amendment. The filing was made by Mitchell P. Kopin, Daniel B. Asher, and Intracoastal Capital LLC, collectively referred to as the Reporting Persons. The Schedule 13G indicates that these Reporting Persons have shared voting and dispositive power over 375,554 shares of Aclarion's common stock, which represents approximately 4.99% of the company's class of securities. This filing was necessitated by a transaction that occurred on the same date, as detailed in a Securities Purchase Agreement (SPA) with Aclarion, which was disclosed in a Form 8-K filed with the SEC on February 27, 2024. The Reporting Persons may have been deemed to have beneficial ownership of additional shares, but due to blocker provisions in the warrants, their beneficial ownership is limited to 4.99% of the common stock. The principal business offices for Mr. Kopin and Intracoastal are located in Delray Beach, Florida, while Mr. Asher's office is in Chicago, Illinois. The filing asserts that the shares were not acquired for the purpose of changing or influencing the control of Aclarion, Inc.
2024年2月26日，在美國證券交易委員會上市的公司Aclarion, Inc. 經歷了一起涉及提交附表13G修正案的重大事件。該文件由米切爾·科平、丹尼爾·阿舍爾和Intracoastal Capital LLC（統稱爲 “申報人”）提交。附表13G指出，這些申報人對Aclarion普通股的375,554股共享投票權和處置權，該普通股約佔公司證券類別的4.99％。正如與Aclarion簽訂的證券購買協議（SPA）所詳述的那樣，該文件是由於同一天發生的一筆交易所必需的，該協議在2024年2月27日向美國證券交易委員會提交的8-K表格中披露。申報人可能被視爲擁有額外股份的實益所有權，但由於認股權...展開全部
2024年2月26日，在美國證券交易委員會上市的公司Aclarion, Inc. 經歷了一起涉及提交附表13G修正案的重大事件。該文件由米切爾·科平、丹尼爾·阿舍爾和Intracoastal Capital LLC（統稱爲 “申報人”）提交。附表13G指出，這些申報人對Aclarion普通股的375,554股共享投票權和處置權，該普通股約佔公司證券類別的4.99％。正如與Aclarion簽訂的證券購買協議（SPA）所詳述的那樣，該文件是由於同一天發生的一筆交易所必需的，該協議在2024年2月27日向美國證券交易委員會提交的8-K表格中披露。申報人可能被視爲擁有額外股份的實益所有權，但由於認股權證中的凍結條款，其受益所有權僅限於普通股的4.99％。Kopin先生和Intracoastal的主要業務辦公室位於佛羅里達州的德拉海灘，而阿舍爾先生的辦公室位於伊利諾伊州的芝加哥。該文件稱，收購這些股票不是爲了改變或影響Aclarion, Inc.的控制權。
有用
沒用